Ophthalmic use of muscarinic agonists having increased duration

Details Ophthalmic use of muscarinic agonists having increased duration Ophthalmic use of muscarinic agonists having increased duration

1993-04-13

1996-05-28

Kumar, Shailendra

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514408, 514422, 514912, 514913, A61K 3140

Patent

active

055212107

ABSTRACT:
A method for inducing prolonged pseudoaccommodation includes the instillation of an ophthalmic formulation into an eye for contracting the iris sphincter muscle, but not the ciliary muscle, in order to cause sphincter muscle contraction for a period of greater than about one hour per installation. The method further provides for the stabilization of an implanted intraocular lens immediately after surgery and for reducing glare following radial keratotomy.

REFERENCES:
patent: 3444185 (1969-05-01), Pierre et al.
patent: 3450814 (1969-06-01), Bechtold et al.
patent: 3608073 (1971-09-01), Kaspar et al.
patent: 3824313 (1974-07-01), Smythies
patent: 3920824 (1975-11-01), Rajadhyaksha
patent: 3947573 (1976-03-01), Rankin
patent: 3978201 (1976-08-01), Khromou et al.
patent: 4003991 (1977-01-01), Krohn et al.
patent: 4136178 (1979-01-01), Lin et al.
patent: 4407792 (1983-10-01), Schoenwald et al.
patent: 4597965 (1986-07-01), Holly
patent: 4668506 (1987-05-01), Bawa
patent: 4742073 (1988-05-01), Bundgaard et al.
Investigative Ophthalmology vol. 14, No. 3 1975 pp. 232-235.
Archives of Pharmacology vol. 338, No. 5, 1988 pp. 476-483.
Journal of Medicinal Chemistry vol. 31, No. 3, 1988 pp. 683-688.
Exp. Eye Res. vol. 56, No. 4, Apr. 1, 1993, pp. 385-392.
The Japanese Journal of Pharmacology vol. 38 No. 1, 1985.

Affiliated with

Also associated with

Rating

Ophthalmic use of muscarinic agonists having increased duration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic use of muscarinic agonists having increased duration , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic use of muscarinic agonists having increased duration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-787252